SNTI

Senti Biosciences, Inc. (SNTI) SWOT Analysis Analysis (2026)

Invetso Score: 2.4/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 2.8 (Weak)

Negative net debt and a current ratio near 0.83 indicate limited leverage burden, but peers with stronger liquidity still retain greater financial flexibility.

ROIC of -2.3% shows capital is not yet earning above cost, leaving SNTI structurally behind profitable peers on value creation.

The absence of disclosed operating and gross margins limits evidence of durable unit economics, whereas peer filings typically show clearer margin resilience.

A very high cash conversion cycle suggests working-capital drag, but this is more a weakness than a strength versus faster-converting peers.

Weaknesses

Score:

ROIC of -2.3% signals persistent capital inefficiency, leaving SNTI materially weaker than peers that generate positive returns on invested capital.

Current and quick ratios of 0.83 imply tight near-term liquidity, while stronger peers typically maintain buffers above one for operating resilience.

The cash conversion cycle of 3,170 days indicates severe working-capital strain, far worse than peers with shorter cycles and faster cash recovery.

Negative debt-to-equity and net debt metrics likely reflect balance-sheet distortions rather than strength, limiting comparability and obscuring true financial flexibility.

Opportunities

Score:

If SNTI improves working-capital discipline, the extreme cash conversion cycle could compress materially, creating a larger relative uplift than for peers already efficient.

Any move toward positive ROIC would narrow the gap with profitable peers and improve structural capital allocation credibility over a 2–5 year horizon.

Liquidity normalization above one on current and quick ratios would reduce refinancing pressure and align SNTI more closely with better-capitalized peers.

Because margin data are not disclosed here, future filings that demonstrate stable gross and operating margins could materially re-rate peer positioning.

Threats

Score:

Sustained sub-1 liquidity ratios increase the risk of operational stress, especially versus peers that can fund inventory and receivables without external support.

Negative ROIC leaves SNTI vulnerable to capital dilution or underinvestment, while stronger peers can reinvest internally at higher returns.

The extreme cash conversion cycle can trap cash in operations, making SNTI more exposed than peers to demand shocks and supplier tightening.

If peers continue to compound positive returns and cleaner balance sheets, SNTI’s relative positioning may weaken further through slower self-funded growth.

Overall Score

Score:

SNTI’s peer positioning is structurally weak because negative returns, tight liquidity, and severe working-capital inefficiency outweigh any limited balance-sheet flexibility.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Senti Biosciences, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →